These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12876530)

  • 21. Human chorionic gonadotropin and CA 15-3 producing adenocarcinoma.
    Uçkaya G; Ozet A; Arpaci A; Kömürcü S
    Nuklearmedizin; 1998; 37(8):297-8. PubMed ID: 9868713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic strategies in cervical carcinoma of an unknown primary (CUP).
    Haas I; Hoffmann TK; Engers R; Ganzer U
    Eur Arch Otorhinolaryngol; 2002 Jul; 259(6):325-33. PubMed ID: 12115082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic carcinoma of unknown primary: diagnostic approach using immunohistochemistry.
    Conner JR; Hornick JL
    Adv Anat Pathol; 2015 May; 22(3):149-67. PubMed ID: 25844674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination of MUC5ac and WT-1 immunohistochemistry is useful in distinguishing pancreatic ductal carcinoma from ovarian serous carcinoma in effusion cytology.
    Han L; Pansare V; Al-Abbadi M; Husain M; Feng J
    Diagn Cytopathol; 2010 May; 38(5):333-6. PubMed ID: 19856421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement.
    Judson K; McCormick C; Vang R; Yemelyanova AV; Wu LS; Bristow RE; Ronnett BM
    Int J Gynecol Pathol; 2008 Apr; 27(2):182-90. PubMed ID: 18317225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of positron emission tomography (PET) in the management of cervical lymph nodes metastases from an unknown primary tumour.
    Mevio E; Gorini E; Sbrocca M; Artesi L; Mullace M; Caimi F
    Acta Otorhinolaryngol Ital; 2004 Dec; 24(6):342-7. PubMed ID: 15952684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Axillary metastases of unknown primary carcinoma].
    Ellend A; Obwegeser R; Auerbach L; Czerwenka K; Kubista E
    Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):209-13. PubMed ID: 8682287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site].
    Bugat R; Bataillard A; Lesimple T; Voigt JJ; Culine S; Lortholary A; Merrouche Y; Ganem G; Kaminsky MC; Negrier S; Perol M; Laforêt C; Bedossa P; Bertrand G; Coindre JM; Fizazi K;
    Bull Cancer; 2002 Oct; 89(10):869-75. PubMed ID: 12441278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of an immunohistochemical diagnostic panel to determine the primary site of cervical lymph node metastases of occult squamous cell carcinoma.
    Park JM; Jung CK; Choi YJ; Lee KY; Kang JH; Kim MS; Hu HJ
    Hum Pathol; 2010 Mar; 41(3):431-7. PubMed ID: 19954817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy.
    Rougraff BT; Kneisl JS; Simon MA
    J Bone Joint Surg Am; 1993 Sep; 75(9):1276-81. PubMed ID: 8408149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and treatment of unknown primary tumors].
    Dodion P; De Valeriola D
    Bull Cancer; 1989; 76(9):939-46. PubMed ID: 2695183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occult breast carcinoma presenting with axillary lymph node metastases.
    Medina-Franco H; Urist MM
    Rev Invest Clin; 2002; 54(3):204-8. PubMed ID: 12183889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metastases of unknown origin--principles of diagnosis and treatment].
    Petrović D; Muzikravić L; Jovanović D
    Med Pregl; 2007; 60(1-2):29-36. PubMed ID: 17853708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult metastases in the axillary lymph nodes of patients with breast cancer node negative by clinical and histologic examination and conventional histology.
    Chen ZL; Wen DR; Coulson WF; Giuliano AE; Cochran AJ
    Dis Markers; 1991; 9(5):239-48. PubMed ID: 1724633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supraclavicular lymph node metastases of unknown origin: HPV-typing identifies the primary tumour.
    Kuemper C; Burges A; Hillemanns P; Mueller-Egloff S; Lenhard M; Ditsch N; Strauss A
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):606-11. PubMed ID: 19549285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.